Paxman: Interim data from Cryotherapy study in Singapore - Redeye

Redeye comments on the published interim data from the MASCC/AFSOS/ISOO 2004 annual meeting in Lille on Saturday, based on the Single-arm phase I-II study in Singapore. The encouraging results reinforce our view that this is an excellent optionality for the company.

Länk till analysen i sin helhet: https://www.redeye.se/research/1017512/paxman-interim-data-from-cryotherapy-study-in-singapore?utm_source=finwire&utm_medium=RSS